Thursday, April 10, 2008, to be Proclaimed Light San Diego Pink Day
SAN DIEGO, April 8, 2008 /PRNewswire/ -- Susan G. Komen for the Cure, the world's largest grassroots network of breast cancer survivors and activists committed to ending breast cancer forever, announced today that its San Diego Affiliate will award $960,000 in grants to local agencies. These grants are to help the uninsured and underinsured women and men in San Diego receive breast cancer education, screening and treatment services. In recognition of Susan G. Komen for the Cure, San Diego's outstanding service, leadership, and commitment to area residents, the San Diego County Board of Supervisors will declare Thursday, April 10, 2008, Light San Diego Pink Day.
Since its inception in 1995, Susan G. Komen for the Cure, San Diego, has awarded more than $6 million in grants in an effort to close the gaps in care, that make breast cancer deadlier for some women, which contributed to the 4,156 breast cancer deaths last year in California alone. According to a Community Assessment conducted by Susan G. Komen for the Cure, San Diego in 2006, San Diego women with a low-income and of a racial minority -- particularly Latina and African-American women -- are less likely to survive breast cancer.
Often it is a matter of disparity in access to screening and treatment as well as a lack of education about the disease that leads to deadly late-stage diagnoses. Additionally, according to the American Cancer Society, 21 percent of women in California have no health insurance. While nearly two out of three insured women over 40 had a mammogram last year, only one third of their uninsured counterparts did.
"Breast cancer at its early stage is more often detected in women in
higher-income groups than those in lower incomes, and the reality today is
that the difference between life and death often depends on when a patient
is diagnosed," stated Laura Farmer Sherman, executive director
'/>"/>
| SOURCE Susan G. Komen for the Cure, San Diego Copyright©2008 PR Newswire. All rights reserved |